HighTower Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,480
Closed -$439K – 3983
2026
Q2
$439K Buy
+7,480
New +$314K ﹤0.01% 2865
2025
Q1
– Sell
-16,630
Closed -$659K – 4064
2024
Q4
$659K Buy
16,630
+305
+2% +$11.5K ﹤0.01% 2264
2024
Q3
$554K Buy
+16,325
New +$459K ﹤0.01% 2328
2019
Q2
– Sell
-17,400
Closed -$435K – 2518
2019
Q1
$435K Buy
+17,400
New +$332K ﹤0.01% 1530
2015
Q2
– Sell
-10,937
Closed -$80K – 1726
2015
Q1
$80K Hold
10,937
– – ﹤0.01% 1513
2014
Q4
$106K Hold
10,937
– – ﹤0.01% 1472
2014
Q3
$107K Hold
10,937
– – ﹤0.01% 1429
2014
Q2
$187K Buy
+10,937
New +$157K ﹤0.01% 1417

Other funds holding VCYT

HighTower Advisors's VCYT Position: Q3 2026 in Review

HighTower Advisors sold out of Veracyte (VCYT) in Q3 2026, closing a stake of 7,480 shares — an estimated $439K sold.

HighTower Advisors first reported a position in VCYT in Q2 2014 and held it in 8 quarters. The position peaked at $659K in Q4 2024. 381 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • HighTower Advisors reported no remaining Veracyte position as of Q3 2026 after selling out during the quarter.
  • HighTower Advisors sold 7,480 Veracyte shares in Q3 2026, an estimated $439K.
  • HighTower Advisors first reported a position in Veracyte in Q2 2014 and held it in 8 quarters.
  • HighTower Advisors's Veracyte position peaked at $659K in Q4 2024.
  • 381 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.